GAMMA Investing »

Actuate Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-03-31 $784 286 2.74

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Ishares Inc Core Msci Emkt Etf (IEMG)
Tesla Common Stock (TSLA)
Ishares Tr National Mun Etf Etf (MUB)
Eli Lilly Common Stock (LLY)
Exxon Mobil Corp Common Stock (XOM)
Vanguard Bd Index Fds Intermed Term Etf (BIV)

View all positions for GAMMA Investing

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Northern Trust
Texas Capital Bank Wealth Management Services
Vanguard Fiduciary Trust
State Street Corporation
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group
Deutsche Bank Aktiengesellschaft

View all funds holding Actuate Therapeutics